Close Menu
  • News
  • Stocks
  • Bonds
  • Commodities
  • Collectables
    • Art
    • Classic Cars
    • Whiskey
    • Wine
  • Trading
  • Alternative Investment
  • Markets
  • More
    • Economy
    • Money
    • Business
    • Personal Finance
    • Investing
    • Financial Planning
    • ETFs
    • Equities
    • Funds

Subscribe to Updates

Get the latest markets and assets news and updates directly to your inbox.

Trending Now

Performa Delays Golden Lion–Winning Artist’s New Work Due to US Government Shutdown

November 4, 2025

Philadelphia Art Museum’s director ousted following divisive rebrand – The Art Newspaper

November 4, 2025

Obesity drugs may get Medicare access under deal with White House: reports

November 4, 2025
Facebook X (Twitter) Instagram
Facebook X (Twitter) Instagram
The Asset ObserverThe Asset Observer
Newsletter
LIVE MARKET DATA
  • News
  • Stocks
  • Bonds
  • Commodities
  • Collectables
    • Art
    • Classic Cars
    • Whiskey
    • Wine
  • Trading
  • Alternative Investment
  • Markets
  • More
    • Economy
    • Money
    • Business
    • Personal Finance
    • Investing
    • Financial Planning
    • ETFs
    • Equities
    • Funds
The Asset ObserverThe Asset Observer
Home»Stocks
Stocks

Chemours names Denise Dignam as President and CEO By Investing.com

News RoomBy News RoomMarch 24, 2024
Share
Facebook Twitter LinkedIn Pinterest Email

© Reuters.

WILMINGTON, Del. – The Chemours Company (NYSE:), a prominent player in the global chemical industry, announced today the elevation of Denise Dignam to the permanent roles of President and Chief Executive Officer. Dignam, who has been serving as the Interim CEO since February 2024, also joins the company’s Board of Directors with immediate effect.

With over 35 years of industry experience, Dignam has been part of Chemours since 2015, contributing significantly to its Titanium Technologies and Advanced Performance Materials segments, which together accounted for more than two-thirds of the company’s net sales last year.

Her leadership in these segments is credited with operational savings and strategic shifts towards customer value and resource efficiency.

Dignam’s appointment comes with the endorsement of the Board and Chair Dawn Farrell, who commended her for her proven track record and capability to create shareholder value while adhering to the company’s core values and customer commitment.

In her statement, Dignam expressed her dedication to advancing Chemours by focusing on high-value and emerging growth opportunities, operational efficiency, and safety. She also emphasized the importance of transparency and the collective effort of Chemours’ employees globally.

Concurrently, Matthew S. Abbott will continue as the Interim Chief Financial Officer while the company seeks a permanent CFO. Abbott’s leadership is recognized as pivotal to the company’s financial progress and controls environment.

Diane Iuliano Picho is appointed as the Interim President of the Titanium Technologies segment during the search for a permanent segment President. Picho’s diverse 40-year career spans R&D, operations, HR, and commercial leadership, bringing a wealth of experience to the role.

Chemours, headquartered in Wilmington, Delaware, operates in various sectors, providing market-defining products and chemistry-based innovations. The company’s portfolio includes well-known brands like Ti-Pure™, Opteon™, and Teflon™. It serves a global customer base across approximately 110 countries with about 6,200 employees.

The information in this article is based on a press release statement from The Chemours Company.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Read the full article here

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Obesity drugs may get Medicare access under deal with White House: reports

Here’s how Pinterest’s holiday quarter just became a worry for Wall Street

Cava trims sales outlook amid heavy competition. But it’s wary of diving into the discounting fray.

Stadiums, shows abroad keep Live Nation upbeat on next year after sales miss expectations

Palantir was the most expensive stock ever for a company of its size — until the selloff

Bitcoin slips below $100,000 for first time since June. Here’s where it might be headed next.

Opinion: A deeper dive into Fed rate cuts and China trade reveals these investing ideas

This GE, Amazon-backed electric-plane maker sees strong demand for its IPO

Pfizer’s revenue falls as COVID sales and vaccine recommendations continue to fade

Recent Posts
  • Performa Delays Golden Lion–Winning Artist’s New Work Due to US Government Shutdown
  • Philadelphia Art Museum’s director ousted following divisive rebrand – The Art Newspaper
  • Obesity drugs may get Medicare access under deal with White House: reports
  • Here’s how Pinterest’s holiday quarter just became a worry for Wall Street
  • Cava trims sales outlook amid heavy competition. But it’s wary of diving into the discounting fray.

Subscribe to Newsletter

Get the latest markets and assets news and updates directly to your inbox.

Editors Picks

Philadelphia Art Museum’s director ousted following divisive rebrand – The Art Newspaper

November 4, 2025

Obesity drugs may get Medicare access under deal with White House: reports

November 4, 2025

Here’s how Pinterest’s holiday quarter just became a worry for Wall Street

November 4, 2025

Cava trims sales outlook amid heavy competition. But it’s wary of diving into the discounting fray.

November 4, 2025

WGC: Investment Key Driver of Gold Demand in Q3 2025

November 4, 2025
Facebook X (Twitter) Instagram
© 2025 The Asset Observer. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Press Release
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.